Oxurion NV (OXUR.BR)
EUR 0.1
(1.11%)
EUR 0.1
(1.11%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -0.01 EUR | 100.0% |
| 2022 | -3726.80 EUR | -490268.42% |
| 2021 | -0.76 EUR | -4.11% |
| 2020 | -0.73 EUR | 45.93% |
| 2019 | -1.35 EUR | -33.66% |
| 2018 | -1.01 EUR | -260.32% |
| 2017 | 0.63 EUR | 137.72% |
| 2016 | -1.67 EUR | -59.05% |
| 2015 | -1.05 EUR | 26.06% |
| 2014 | -1.42 EUR | -300.0% |
| 2013 | 0.71 EUR | -18.39% |
| 2012 | 0.87 EUR | 229.85% |
| 2011 | -0.67 EUR | -42.55% |
| 2010 | -0.47 EUR | 11.32% |
| 2009 | -0.53 EUR | -212.77% |
| 2008 | 0.47 EUR | 175.81% |
| 2007 | -0.62 EUR | -34.78% |
| 2006 | -0.46 EUR | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | -0.00 EUR | 0.0% |
| 2023 Q2 | -200.00 EUR | 0.0% |
| 2023 Q4 | -23.90 EUR | 0.0% |
| 2023 FY | - EUR | 96.89% |
| 2022 FY | - EUR | 51.32% |
| 2022 Q2 | -0.32 EUR | 0.0% |
| 2022 Q4 | -526.80 EUR | 0.0% |
| 2021 Q2 | -0.41 EUR | 0.0% |
| 2021 Q4 | -0.34 EUR | 0.0% |
| 2021 FY | - EUR | -4.11% |
| 2020 FY | - EUR | 45.93% |
| 2020 Q4 | -0.39 EUR | 0.0% |
| 2020 Q2 | -0.34 EUR | 0.0% |
| 2019 Q2 | -0.87 EUR | 0.0% |
| 2019 Q4 | -0.48 EUR | 0.0% |
| 2019 FY | - EUR | -33.66% |
| 2018 Q2 | -0.39 EUR | 0.0% |
| 2018 Q4 | -0.62 EUR | 0.0% |
| 2018 FY | - EUR | -260.32% |
| 2017 Q4 | 1.03 EUR | 0.0% |
| 2017 FY | - EUR | 137.72% |
| 2017 Q2 | -0.42 EUR | 0.0% |
| 2016 Q4 | -1.24 EUR | 0.0% |
| 2016 Q2 | -0.42 EUR | 0.0% |
| 2016 FY | - EUR | -59.05% |
| 2015 FY | - EUR | 26.06% |
| 2015 Q4 | -0.52 EUR | 0.0% |
| 2015 Q2 | -0.53 EUR | 0.0% |
| 2014 Q4 | -0.76 EUR | 0.0% |
| 2014 Q2 | -0.66 EUR | 0.0% |
| 2014 FY | - EUR | -300.0% |
| 2013 Q2 | 1.48 EUR | 0.0% |
| 2013 Q4 | -0.78 EUR | 0.0% |
| 2013 FY | - EUR | -18.39% |
| 2012 Q1 | 0.21 EUR | 0.0% |
| 2012 FY | - EUR | 229.85% |
| 2012 Q4 | 0.18 EUR | -14.29% |
| 2012 Q2 | 0.21 EUR | 0.0% |
| 2012 Q3 | 0.21 EUR | 0.0% |
| 2011 Q4 | 0.21 EUR | 231.25% |
| 2011 Q1 | -0.16 EUR | 0.0% |
| 2011 Q2 | -0.16 EUR | 0.0% |
| 2011 FY | - EUR | -42.55% |
| 2011 Q3 | -0.16 EUR | 0.0% |
| 2010 FY | - EUR | 11.32% |
| 2010 Q2 | -0.12 EUR | 0.0% |
| 2010 Q1 | -0.12 EUR | 0.0% |
| 2010 Q3 | -0.12 EUR | 0.0% |
| 2010 Q4 | -0.16 EUR | -33.33% |
| 2009 Q1 | -0.13 EUR | 0.0% |
| 2009 FY | - EUR | -212.77% |
| 2009 Q3 | -0.13 EUR | 0.0% |
| 2009 Q2 | -0.13 EUR | 0.0% |
| 2009 Q4 | -0.12 EUR | 7.69% |
| 2008 Q4 | -0.13 EUR | -218.18% |
| 2008 FY | - EUR | 175.81% |
| 2008 Q1 | 0.11 EUR | 0.0% |
| 2008 Q2 | 0.11 EUR | 0.0% |
| 2008 Q3 | 0.11 EUR | 0.0% |
| 2007 Q3 | -0.17 EUR | 0.0% |
| 2007 Q4 | 0.11 EUR | 164.71% |
| 2007 FY | - EUR | -34.78% |
| 2007 Q2 | -0.17 EUR | 0.0% |
| 2007 Q1 | -0.17 EUR | 0.0% |
| 2006 Q4 | -0.17 EUR | -54.55% |
| 2006 FY | - EUR | 0.0% |
| 2006 Q3 | -0.11 EUR | 0.0% |
| 2006 Q2 | -0.11 EUR | 0.0% |
| 2006 Q1 | -0.11 EUR | 0.0% |
| 2005 Q4 | -0.11 EUR | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Nicox S.A. | -0.42 EUR | 97.262% |
| European Medical Solutions | -0.00 EUR | -2200.0% |
| FERMENTALG | -0.32 EUR | 96.406% |
| argenx SE | -4.67 EUR | 99.754% |
| BioSenic S.A. | -0.21 EUR | 94.524% |
| Celyad Oncology SA | -0.33 EUR | 96.515% |
| Hyloris Pharmaceuticals SA | -0.55 EUR | 97.909% |
| Onward Medical N.V. | -1.20 EUR | 99.042% |
| PHAXIAM Therapeutics S.A. | -5.00 EUR | 99.77% |
| Financière de Tubize SA | 1.98 EUR | 100.581% |
| UCB SA | 1.81 EUR | 100.635% |